Financial Statements — HIVE
Balance Sheet
(in millions USD)| Metric | Q1
2027 | Q3
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 |
|---|
| Cash & Equivalents | 208.04 | 14.07 | 9.85 | 22.64 | 24.60 | 7.24 |
| Total Current Assets | 280.03 | 90.86 | 310.26 | 136.67 | 180.65 | 203.52 |
| Total Assets | 924.64 | 624.00 | -- | 692.97 | 628.73 | -- |
| Total Current Liabilities | 143.05 | 52.29 | 29.81 | 53.61 | 52.81 | 36.63 |
| Total Liabilities | 501.94 | 64.72 | -- | 68.37 | 68.21 | -- |
| Retained Earnings | (565.22) | (345.97) | (351.01) | (254.64) | (238.85) | (352.28) |
| Total Stockholder Equity | 422.70 | 559.27 | 434.36 | 624.60 | 560.52 | 279.53 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2027 | Q3
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 |
|---|
| Interest Expense | 0.44 | 0.24 | -- | 0.15 | 0.07 | -- |
| Pretax Income | -- | -- | 1.39 | -- | -- | (7.34) |
| Tax Provision | 1.58 | 0.50 | 0.12 | 1.02 | 0.65 | 0.32 |
| Net Income | (142.91) | (91.33) | 1.27 | (15.80) | 35.02 | (7.66) |
| Basic EPS | (0.54) | (0.38) | 0.01 | (0.07) | 0.19 | (0.06) |
| Diluted EPS | (0.54) | (0.38) | 0.01 | (0.07) | 0.18 | (0.06) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2027 | Q3
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 |
|---|
| Operating Cash Flow | 4.06 | 45.60 | (23.60) | (0.38) | 10.23 | (5.02) |
| Capital Expenditures | 14.75 | -- | -- | -- | -- | -- |
| Free Cash Flow* | (10.69) | -- | -- | -- | -- | -- |
| Investing Cash Flow | (48.12) | (175.88) | (90.46) | (108.10) | (61.96) | (27.97) |
| Financing Cash Flow | 228.56 | 120.55 | 114.33 | 107.33 | 52.85 | 30.50 |
* Derived from reported values
